The c-fes protooncogene is expressed at high levels in the terminal st
ages of granulocytic differentiation. Its product, p92(c-fes), exhibit
s a tyrosine-kinase activity and is involved in the cellular response
to GM-CSF, but its role is not yet clarified. To study this problem, t
he c-fes protooncogene expression has been inhibited in HL60 cells and
in fresh leukemic blast cells of Acute Promyelocylic Leukemia (APL) i
nduced to differentiate with All-Trans-Retinoic Acid (ATRA). Inhibitio
n of c-fes function was obtained by treatment of the cells with a spec
ific antisense oligomer complementary to the 5' region of the c-fes mR
NA. It was observed that the cells, rather then differentiate to granu
locytes, underwent premature cell death showing the morphological and
molecular characteristics of apoptosis. Superimposable results are obt
ained on blast cells from APL. It is possible to conclude that the los
s of cell viability that occurs during the in vitro differentiation of
myeloid cells, after the complete inhibition of c-fes expression and
treatment with ATRA, is due to activation of programmed cell death rat
her than an accelerated differentiation. Our data suggest that the c-f
es product is essential for the survival of myeloid cells during diffe
rentiation.